Your browser is no longer supported. Please, upgrade your browser.
DARE Dare Bioscience, Inc. daily Stock Chart
Dare Bioscience, Inc.
Index- P/E- EPS (ttm)-0.89 Insider Own12.65% Shs Outstand23.80M Perf Week6.25%
Market Cap31.95M Forward P/E- EPS next Y-0.56 Insider Trans0.00% Shs Float23.49M Perf Month14.42%
Income-16.30M PEG- EPS next Q-0.15 Inst Own3.70% Short Float1.10% Perf Quarter9.17%
Sales- P/S- EPS this Y38.00% Inst Trans- Short Ratio0.30 Perf Half Y-9.16%
Book/sh0.14 P/B8.50 EPS next Y11.10% ROA-225.80% Target Price- Perf Year60.31%
Cash/sh0.19 P/C6.39 EPS next 5Y- ROE-616.40% 52W Range0.69 - 2.22 Perf YTD45.12%
Dividend- P/FCF- EPS past 5Y43.00% ROI- 52W High-46.40% Beta1.88
Dividend %- Quick Ratio2.00 Sales past 5Y- Gross Margin- 52W Low72.41% ATR0.09
Employees15 Current Ratio2.00 Sales Q/Q- Oper. Margin- RSI (14)53.36 Volatility4.03% 10.22%
OptionableNo Debt/Eq0.00 EPS Q/Q33.10% Profit Margin- Rel Volume0.65 Prev Close1.20
ShortableYes LT Debt/Eq0.00 EarningsMay 14 BMO Payout- Avg Volume850.42K Price1.19
Recom2.00 SMA20-0.06% SMA509.00% SMA20016.68% Volume556,723 Change-0.83%
Aug-06-20 08:00AM  
Aug-05-20 08:00AM  
Jul-27-20 08:00AM  
Jul-13-20 07:02PM  
Jun-17-20 08:00AM  
Jun-15-20 08:00AM  
Jun-04-20 08:00AM  
May-17-20 03:02PM  
May-14-20 08:00AM  
May-11-20 08:00AM  
May-07-20 08:00AM  
Apr-28-20 08:00AM  
Apr-23-20 08:00AM  
Apr-08-20 04:24PM  
Apr-01-20 08:00AM  
Mar-30-20 02:30PM  
Mar-29-20 09:45AM  
Mar-24-20 08:00AM  
Mar-10-20 08:00AM  
Mar-09-20 08:00AM  
Feb-27-20 08:00AM  
Feb-12-20 04:05PM  
Feb-06-20 08:00AM  
Feb-05-20 08:00AM  
Jan-30-20 08:00AM  
Jan-22-20 06:55AM  
Jan-17-20 12:19PM  
Jan-15-20 08:00AM  
Jan-13-20 07:00AM  
Dec-18-19 08:00AM  
Dec-11-19 08:00AM  
Dec-10-19 08:00AM  
Dec-09-19 07:15AM  
Dec-04-19 03:43PM  
Nov-21-19 08:00AM  
Nov-14-19 08:07AM  
Nov-12-19 08:00AM  
Nov-11-19 08:00AM  
Nov-07-19 08:30AM  
Oct-31-19 08:00AM  
Oct-28-19 08:00AM  
Oct-24-19 08:00AM  
Oct-14-19 08:00AM  
Oct-10-19 08:00AM  
Oct-07-19 08:00AM  
Sep-13-19 02:04PM  
Sep-11-19 08:00AM  
Sep-09-19 12:13PM  
Sep-04-19 08:00AM  
Aug-14-19 04:01PM  
Aug-12-19 01:59PM  
Aug-08-19 08:00AM  
Aug-06-19 08:00AM  
Jul-22-19 08:00AM  
Jul-17-19 08:00AM  
Jul-15-19 08:00AM  
Jul-11-19 03:51PM  
Jun-26-19 08:00AM  
Jun-17-19 08:00AM  
May-29-19 08:00AM  
May-28-19 03:00PM  
May-14-19 04:00PM  
May-08-19 08:00AM  
May-07-19 08:00AM  
Apr-15-19 10:26AM  
Apr-09-19 09:30AM  
Apr-08-19 04:28PM  
Apr-01-19 04:30PM  
Mar-29-19 08:00AM  
Mar-18-19 02:00PM  
Mar-11-19 08:00AM  
Mar-05-19 08:00AM  
Feb-28-19 08:00AM  
Feb-05-19 08:00AM  
Jan-02-19 08:00AM  
Dec-25-18 02:18PM  
Dec-19-18 04:33PM  
Dec-17-18 03:45PM  
Dec-06-18 09:15AM  
Dec-03-18 11:15AM  
Nov-29-18 08:00AM  
Nov-27-18 08:00AM  
Nov-13-18 07:30AM  
Nov-06-18 08:00AM  
Oct-30-18 08:00AM  
Oct-23-18 08:00AM  
Oct-15-18 08:00AM  
Dare Bioscience, Inc., a clinical-stage biopharmaceutical company, focuses on developing and marketing women's reproductive health products in the United States. The company intends to develop therapies in the areas of contraception, vaginal health, sexual health, and fertility. Its product portfolio includes Ovaprene, a non-hormonal monthly contraceptive vaginal ring; Sildenafil Cream, a novel cream formulation of sildenafil to treat female sexual arousal disorder utilizing the active ingredient in Viagra; DARE-BV1, a hydrogel formulation of clindamycin phosphate 2% to treat bacterial vaginosis via a single application; and DARE-HRT1, a combination of bio-identical estradiol and progesterone intravaginal ring for hormone replacement therapy. The company has license agreement with ADVA-Tec, Inc. to develop and commercialize Ovaprene for human contraceptive use; and license and collaboration agreement with Strategic Science and Technologies-D, LLC and Strategic Science Technologies, LLC to develop and commercialize indications for women related to female sexual dysfunction and/or female reproductive health. The company is headquartered in San Diego, California.